Outlines a current study about the influence of diet and physical activity. Conducted by the University of South Carolina and the Palmetto Health system.
Gives details about the clinical trial involving the use of Herceptin as adjuvant therapy in HER2-positive patients with primary breast cancer. This resource is designed for use by patients and investigators.